Drug formulation and delivery – Page 3
-
Business
Pharmaceuticals roundup 2020
Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum
-
Research
Animal tests reveal synthetic decoy protein protects against coronavirus
Protein designed from scratch binds Sars-CoV-2 with high affinity and specificity
-
Article
Faster pharma: Catalytic innovation combats precious metals supply chain pain
Precious metal catalysts are key to pharma but subject to market forces that make reliance on supply a double-edged sword.
-
Article
AI and digital simulation for better medicines, made faster
Revolutionising pharma with next-generation technology to optimise and accelerate drug production processes
-
Research
Fast-acting insecticide polymorph could boost malaria-control efforts
Recrystallised deltamethrin accelerates uptake in mosquitoes
-
Research
Salt bridge strategy expands access to pharmaceutical cocrystals
New approach to cocrystallisation could lead to exciting multi-drug combinations
-
Opinion
Questioning European policy on alkyl mesylate impurities
Policies based on false hypotheses can persist in spite of overwhelming contradictory data
-
Research
Common inactive drug ingredients not as inert as thought
38 out of 639 excipients tested interact with toxicity-related proteins, some reaching levels that might produce unwanted effects
-
News
Suit of iron turns sperm cells into spermbots
Microrobots that swim under the influence of a magnetic field could one day be used to deliver drugs
-
Business
How Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
Business
Micropore Technologies’ model membranes make exact emulsions
Solving scalability issues to control particle size without high-shear mixing
-
Research
MOF delivers cancer drug candidate straight to mitochondria
New ‘Trojan horse’ strategy could reduce drug doses needed to kill cancer cells
-
News
UK researchers receive £20m to start coronavirus treatment research
Two vaccine trials among six projects that win funding
-
Opinion
Fit to 3D print
Construction from the bottom up has benefits but users must proceed with caution
-
Feature
Adjuvants: vaccines’ hidden helpers
Anthony King examines a crucial part of vaccines that can significantly boost their performance, but which often go unrecognised
-
Research
Warning that 3D printing pills can stop drugs working
Photoreactive monomers need close scrutiny for production of polypills
-
Business
Researchers call for stricter rules on drug-like medical devices
More oversight is needed over products in the grey area between medical device and medication
-
Research
Compact pharmaceutical factory manufactures drugs on demand
Plant with modular design would occupy about half the area of a squash court
-
Feature
Can smart biomaterials deliver?
James Mitchell Crow explores the next generation of therapeutic biomaterials, which aim to interact dynamically with the body and help to control diabetes and heal wounds
-
Article
The importance of solid form science in modern drug development
A recent study suggests that around 40% of drugs with market approval exhibit poor water solubility and although this is not a new problem, solutions like those offered by Johnson Matthey are still relevant to today’s pharma market